EUVIMEDEUVIMED entdecken
Crossref

Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls

Hannah Gilliam-Vigh iD, Tina Jorsal iD, Sophie W Nielsen iD, Julie L Forman iD, Jens Pedersen iD, Steen S Poulsen iD, Tina Vilsbøll iD, Filip K Knop iD

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgad372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Hannah Gilliam-Vigh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrointestinal Hormones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Gentofte Hospital, University of Copenhagen, Overlæge Johan Boserup og Lise Boserups Legat.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The hormone secretin (SCT) is released from intestinal S cells and acts via the SCT receptor (SCTR). Circulating SCT levels increase after Roux-en-Y gastric bypass surgery and have been associated with massive weight loss and high remission rates of type 2 diabetes (T2D) linked to these operations. Exogenous SCT was recently shown to reduce ad libitum food intake in healthy volunteers.

Objective

To understand SCT biology and its potential role in T2D pathophysiology, we examined the intestinal mucosal expression profile of SCT and SCTR and evaluated the density of S cells along the intestinal tract of individuals with T2D and healthy controls.

Methods

Using immunohistochemistry and messenger RNA (mRNA) sequencing, we analyzed intestinal mucosa biopsies sampled along the small intestine at 30-cm intervals and from 7 well-defined anatomical sites along the large intestine (during 2 sessions of double-balloon enteroscopy) in 12 individuals with T2D and 12 healthy controls.

Results

Both groups exhibited a progressive and similar decrease in SCT and SCTR mRNA expression and S-cell density along the small intestine, with reductions of 14, 100, and 50 times, respectively, in the ileum compared to the duodenum (used as reference). Negligible amounts of SCTR and SCT mRNA, as well as low S-cell density, were found in the large intestine. No significant differences were observed between the groups.

Conclusion

SCT and SCTR mRNA expression and S-cell density were abundant in the duodenum and decreased along the small intestine. Very low SCT and SCTR mRNA levels and S-cell numbers were observed in the large intestine, without aberrations in individuals with T2D compared to healthy controls.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Gastrointestinal HormonesHumansCarrier ProteinsRNA, MessengerSecretinSignal TransductionReceptors, Gastrointestinal HormoneReceptors, G-Protein-Coupled

Stichwörter der Autor:innen

enteroendocrine cellsimmunohistochemistrymRNA expressionsecretin (SCT)type 2 diabetes

Substanzen

Carrier ProteinsGastrointestinal HormonesRNA, MessengerSecretinsecretin receptorReceptors, Gastrointestinal HormoneReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.
  • Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, 1353 Copenhagen K, Denmark.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
  • Clinical Research, Steno Diabetes Center Copenhagen, 2730 Herlev, Denmark.
  • Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.

ORCID-Profile: Hannah Gilliam-Vigh, Tina Jorsal, Sophie W Nielsen, Julie L Forman, Jens Pedersen, Steen S Poulsen, Tina Vilsbøll, Filip K Knop

Förderung

  • Gentofte Hospital
  • University of Copenhagen
  • Overlæge Johan Boserup og Lise Boserups Legat
  • Novo Nordisk Foundation

Zitieren

APA

Gilliam-Vigh, H., Jorsal, T., Nielsen, S. W., Forman, J. L., Pedersen, J., Poulsen, S. S., Vilsbøll, T., & Knop, F. K. (2023). Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad372

Vancouver

Gilliam-Vigh H, Jorsal T, Nielsen SW, Forman JL, Pedersen J, Poulsen SS, et al. Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad372

BibTeX
@article{GilliamVigh2023,
  author = {Gilliam-Vigh, Hannah and Jorsal, Tina and Nielsen, Sophie W and Forman, Julie L and Pedersen, Jens and Poulsen, Steen S and Vilsbøll, Tina and Knop, Filip K},
  title = {Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgad372}
}
Kostenlos starten →